Exchange Capital Management, Inc. Amgen Inc Transaction History

Exchange Capital Management, Inc.

$593 Million
Q3 2024

A detailed history of Exchange Capital Management, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Exchange Capital Management, Inc. holds 16,871 shares of AMGN stock, worth $4.44 Million. This represents 0.92% of its overall portfolio holdings.

Number of Shares

16,871

Previous 17,225 2.06%

Holding current value

$4.44 Million

Previous $5.38 Million 1.02%

% of portfolio

0.92%

Previous 0.9%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	SELL	$309.38 - $337.38 $109,520 - $119,432	-354 Reduced 2.06%	16,871 $5.44 Million
Q2 2024 Jul 23, 2024	SELL	$262.75 - $319.31 $143,198 - $174,023	-545 Reduced 3.07%	17,225 $5.38 Million
Q1 2024 Apr 18, 2024	SELL	$268.87 - $324.56 $19,896 - $24,017	-74 Reduced 0.41%	17,770 $5.05 Million
Q4 2023 Feb 08, 2024	SELL	$255.7 - $288.46 $102,280 - $115,383	-400 Reduced 2.19%	17,844 $5.14 Million
Q3 2023 Oct 30, 2023	SELL	$218.65 - $271.46 $72,810 - $90,396	-333 Reduced 1.79%	18,244 $4.9 Million
Q2 2023 Jul 24, 2023	SELL	$214.27 - $253.37 $50,567 - $59,795	-236 Reduced 1.25%	18,577 $4.12 Million
Q1 2023 May 03, 2023	SELL	$225.79 - $275.2 $14,676 - $17,888	-65 Reduced 0.34%	18,813 $4.55 Million
Q4 2022 Jan 31, 2023	SELL	$229.03 - $291.01 $160,779 - $204,289	-702 Reduced 3.59%	18,878 $4.96 Million
Q3 2022 Oct 31, 2022	SELL	$224.46 - $253.15 $145,450 - $164,041	-648 Reduced 3.2%	19,580 $4.41 Million
Q2 2022 Jul 28, 2022	SELL	$230.71 - $256.74 $139,810 - $155,584	-606 Reduced 2.91%	20,228 $4.92 Million
Q1 2022 Apr 28, 2022	SELL	$219.27 - $242.57 $82,226 - $90,963	-375 Reduced 1.77%	20,834 $5.04 Million
Q4 2021 Jan 27, 2022	SELL	$198.88 - $227.6 $115,748 - $132,463	-582 Reduced 2.67%	21,209 $4.77 Million
Q3 2021 Nov 01, 2021	SELL	$212.27 - $248.7 $290,173 - $339,972	-1,367 Reduced 5.9%	21,791 $4.63 Million
Q2 2021 Aug 05, 2021	SELL	$233.58 - $259.14 $131,271 - $145,636	-562 Reduced 2.37%	23,158 $5.65 Million
Q1 2021 May 10, 2021	SELL	$221.91 - $258.6 $131,592 - $153,349	-593 Reduced 2.44%	23,720 $5.9 Million
Q4 2020 Feb 05, 2021	BUY	$216.38 - $257.67 $56,042 - $66,736	259 Added 1.08%	24,313 $5.59 Million
Q3 2020 Nov 06, 2020	SELL	$234.65 - $260.95 $7,508 - $8,350	-32 Reduced 0.13%	24,054 $6.11 Million
Q2 2020 Aug 04, 2020	SELL	$197.81 - $242.74 $144,401 - $177,200	-730 Reduced 2.94%	24,086 $5.68 Million
Q1 2020 Apr 28, 2020	SELL	$182.24 - $241.7 $150,712 - $199,885	-827 Reduced 3.23%	24,816 $5.03 Million
Q4 2019 Jan 29, 2020	SELL	$189.21 - $243.2 $160,260 - $205,990	-847 Reduced 3.2%	25,643 $6.18 Million
Q3 2019 Nov 07, 2019	BUY	$174.11 - $208.62 $23,504 - $28,163	135 Added 0.51%	26,490 $5.13 Million
Q2 2019 Jul 22, 2019	BUY	$166.7 - $195.41 $500 - $586	3 Added 0.01%	26,355 $4.86 Million
Q1 2019 Apr 17, 2019	BUY	$180.87 - $203.88 $217,767 - $245,471	1,204 Added 4.79%	26,352 $5.01 Million
Q4 2018 Feb 01, 2019	BUY	$178.4 - $208.25 $95,979 - $112,038	538 Added 2.19%	25,148 $4.9 Million
Q3 2018 Oct 25, 2018	SELL	$185.29 - $208.89 $22,605 - $25,484	-122 Reduced 0.49%	24,610 $5.1 Million
Q2 2018 Aug 01, 2018	BUY	$166.05 - $186.51 $24,243 - $27,230	146 Added 0.59%	24,732 $4.57 Million
Q1 2018 May 03, 2018	BUY	$169.43 - $198.0 $25,753 - $30,096	152 Added 0.62%	24,586 $4.19 Million
Q4 2017 May 07, 2018	BUY	$168.79 - $188.59 $394,124 - $440,357	2,335 Added 10.57%	24,434 $4.25 Million
Q4 2017 Feb 05, 2018	SELL	$168.79 - $188.59 $266,013 - $297,217	-1,576 Reduced 6.66%	22,099 $3.84 Million
Q3 2017 Nov 02, 2017	BUY	$167.29 - $191.0 $3.96 Million - $4.52 Million	23,675	23,675 $4.41 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Exchange Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Exchange Capital Management, Inc. with notifications on news.

Account

Exchange Capital Management, Inc. Amgen Inc Transaction History